Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Immunosyn Corp.
Fiscal year is January-December. All values USD millions. 2006 2007 2008 2009 5-year trend
Sales/Revenue - 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A - 0 1,179 1,287 1,286
COGS excluding D&A - 0 0 0 0
Depreciation & Amortization Expense - 0 1,179 1,287 1,286
Depreciation - 0 1,179 1,287 1,286
Amortization of Intangibles - 0 0 0 0
Gross Income - 0 (1,179) (1,287) (1,286)
2006 2007 2008 2009 5-year trend
SG&A Expense - 155,763 645,598 1.04M 731,549
Research & Development - 0 0 0 0
Other SG&A - 155,763 645,598 1.04M 731,549
Other Operating Expense - 0 0 0 1.95M
Unusual Expense - 0 0 0 0
EBIT after Unusual Expense - 0 0 0 0
Non Operating Income/Expense - 0 0 0 0
Non-Operating Interest Income - - - - -
Equity in Affiliates (Pretax) - 0 0 0 0
Interest Expense - 0 26,060 61,326 93,663
Gross Interest Expense - 0 26,060 61,326 93,663
Interest Capitalized - 0 0 0 0
Pretax Income - (155,763) (672,837) (1.11M) (2.77M)
Income Tax - 0 0 0 0
Income Tax - Current Domestic - 0 0 0 0
Income Tax - Current Foreign - 0 0 0 0
Income Tax - Deferred Domestic - 0 0 0 0
Income Tax - Deferred Foreign - 0 0 0 0
Income Tax Credits - 0 0 0 0
Equity in Affiliates - 0 0 0 0
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income - (155,763) (672,837) (1.11M) (2.77M)
Minority Interest Expense - 0 0 0 0
Net Income - (155,763) (672,837) (1.11M) (2.77M)
Extraordinaries & Discontinued Operations - 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations - 0 0 0 0
Net Income After Extraordinaries - (155,763) (672,837) (1.11M) (2.77M)
Preferred Dividends - 0 0 0 0
Net Income Available to Common - (155,763) (672,837) (1.11M) (2.77M)
EPS (Basic) - () () () (0.01)
Basic Shares Outstanding - 216.14M 272M 272.11M 270.67M
EPS (Diluted) - () () () (0.01)
Diluted Shares Outstanding - 216.14M 272M 272.11M 270.67M
EBITDA - (155,763) (645,598) (1.04M) (2.68M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.